85 related articles for article (PubMed ID: 18068792)
21. Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw.
Wat WZM
Dent J (Basel); 2016 Oct; 4(4):. PubMed ID: 29563480
[TBL] [Abstract][Full Text] [Related]
22. Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ).
Berg BI; Mueller AA; Augello M; Berg S; Jaquiéry C
Dent J (Basel); 2016 Sep; 4(3):. PubMed ID: 29563471
[TBL] [Abstract][Full Text] [Related]
23. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
24. Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats.
Silveira FM; Etges A; Correa MB; Vasconcelos AC
J Oral Maxillofac Res; 2016; 7(4):e3. PubMed ID: 28154747
[TBL] [Abstract][Full Text] [Related]
25. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?
Klingelhöffer C; Klingelhöffer M; Müller S; Ettl T; Wahlmann U
Dentomaxillofac Radiol; 2016; 45(5):20160065. PubMed ID: 27213837
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
Koth VS; Figueiredo MA; Salum FG; Cherubini K
Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of BP-ONJ in osteopenic and healthy sheep: comparing ZTE-MRI with µCT.
Voss P; Ludwig U; Poxleitner P; Bergmaier V; El-Shafi N; von Elverfeldt D; Stadelmann V; Hövener JB; Flügge T
Dentomaxillofac Radiol; 2016; 45(4):20150250. PubMed ID: 26846710
[TBL] [Abstract][Full Text] [Related]
28. Mandibular inferior cortical bone thickness on panoramic radiographs in patients using bisphosphonates.
Torres SR; Chen CS; Leroux BG; Lee PP; Hollender LG; Lloid M; Drew SP; Schubert MM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 May; 119(5):584-92. PubMed ID: 25864820
[TBL] [Abstract][Full Text] [Related]
29. Concomitant factors leading to an atypical osteonecrosis of the jaw in a patient with multiple myeloma.
Miranda-Rius J; Brunet-Llobet L; Lahor-Soler E; Giménez-Rubio JA
Case Rep Med; 2014; 2014():281313. PubMed ID: 25140178
[TBL] [Abstract][Full Text] [Related]
30. Implications of three-phase bone scintigraphy for the diagnosis of bisphosphonate-related osteonecrosis of the jaw.
Hong CM; Ahn BC; Choi SY; Kim DH; Lee SW; Kwon TG; Lee J
Nucl Med Mol Imaging; 2012 Sep; 46(3):162-8. PubMed ID: 24900055
[TBL] [Abstract][Full Text] [Related]
31. Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?
De Ceulaer J; Tacconelli E; Vandecasteele SJ
Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1873-80. PubMed ID: 24880820
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate related osteonecrosis of the jaw: a study of 18 cases associated with fungal infection.
Aftimos V; Zeinoun T; Bou Tayeh R; Aftimos G
Int J Dent; 2014; 2014():869067. PubMed ID: 24696686
[TBL] [Abstract][Full Text] [Related]
33. Radiolucent lesions of the mandible: a pattern-based approach to diagnosis.
Avril L; Lombardi T; Ailianou A; Burkhardt K; Varoquaux A; Scolozzi P; Becker M
Insights Imaging; 2014 Feb; 5(1):85-101. PubMed ID: 24323536
[TBL] [Abstract][Full Text] [Related]
34. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
35. Skeletal complications of bisphosphonate use: what the radiologist should know.
Haworth AE; Webb J
Br J Radiol; 2012 Oct; 85(1018):1333-42. PubMed ID: 22972971
[TBL] [Abstract][Full Text] [Related]
36. Imaging findings in bisphosphonate-induced osteonecrosis of the jaws.
Popovic KS; Kocar M
Radiol Oncol; 2010 Dec; 44(4):215-9. PubMed ID: 22933918
[TBL] [Abstract][Full Text] [Related]
37. Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Bedogni A; Fusco V; Agrillo A; Campisi G
Oral Dis; 2012 Sep; 18(6):621-3. PubMed ID: 22353421
[No Abstract] [Full Text] [Related]
38. Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis.
Torres SR; Chen CS; Leroux BG; Lee PP; Hollender LG; Schubert MM
Dentomaxillofac Radiol; 2011 Dec; 40(8):501-5. PubMed ID: 22065799
[TBL] [Abstract][Full Text] [Related]
39. Differentiating osteoradionecrosis from nasopharyngeal carcinoma tumour recurrence using ⁹⁹Tcm-sestamibi SPECT/CT.
Tan AE; Ng DC
Br J Radiol; 2011 Sep; 84(1005):e172-5. PubMed ID: 21849357
[TBL] [Abstract][Full Text] [Related]
40. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.
Yoneda T; Hagino H; Sugimoto T; Ohta H; Takahashi S; Soen S; Taguchi A; Toyosawa S; Nagata T; Urade M
J Bone Miner Metab; 2010 Jul; 28(4):365-83. PubMed ID: 20333419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
